3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study.non-small cell lung carcinomaRecruitingPhase 22025-12-04NCT07264673
Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and DurvalumabNon-small-cell Lung Cancer PatientsRecruitingPhase 22025-12-01NCT05568212
NTRK 1,2,3 Rearrangements in Patients With Solid TumorsNTRK1/2/3 Fusion Gene DetectionActive, not recruitingNot stated2025-01-17NCT06780384